Bloomberg Talks cover image

Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill

Bloomberg Talks

00:00

Competing with Lilly's oral GLP-1

Katie questions competition; Mike contrasts phase‑three data and efficacy parity with injections.

Play episode from 01:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app